(1 - 29 von 33
)
Merck aquired AmpTec to expand mRNA capabilities
european-biotechnology.com
Vefur27. des · by Dr. Peter Scheinert, Managing Director & founder of AmpTec GmbH This year, Merck KGaA Darmstadt, Germany has acquired AmpTec, an internationally …
Merck/AmpTec: New mRNA manufacturing site opened in Hamburg
www.lifesciencenord.de
VefurPeter Scheinert, Founder & CEO of Amptec GmbH Facing the Challenge > - AmpTec AmpTec is an internationally leading provider of RNA technology products, …
Online-Update Hygiene und Infektionsprävention Dr. Brill Academybrillinstitutes.com
academy.brillinstitutes.com
Dr. Peter Scheinert. Messenger-Ribonukleinsäure(mRNA) im Kontext von Covid-19: Impfstoffe, Therapien und Diagnostika. Managing Director & Founder AmpTec ...
Merck Acquires AmpTec to Expand mRNA Capabilities for Vaccines,...
www.prnewswire.co.uk
· ... Guido Krupp and Peter Scheinert, managing directors and founders of AmpTec. "AmpTec's more than 40 employees are thrilled to join Merck ...
sortiert nach Relevanz / Datum